Pacemaker Market Size, Share & Trends Analysis Report By Product (External, Implantable), By Application (Arrhythmias, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2025 - 2030

Pacemaker Market Size, Share & Trends Analysis Report By Product (External, Implantable), By Application (Arrhythmias, Congestive Heart Failure), By End Use, By Region, And Segment Forecasts, 2025 - 2030


Door Phone Market Growth & Trends

The global door phone market size is expected to reach USD 6.00 billion by 2030, registering a CAGR of 3.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is driven by consumer spending on security and safety products for home, along with rise in demand from the multi storage residential buildings. Moreover, cost of keeping manual security at every place in a premise is much costlier as compared to the automated security devices, thereby resulting in increased sale of door phones in the market.

The market is driven by increasing number of smart and automated homes in Asia Pacific, along with availability of cost effective products from various regional manufacturers. It can also be integrated with the central security system of the building, thereby making home monitoring easier and safer. These products are highly demanding for physically handicapped and old people in the house for whom every time when the bell rings, running down from the top floor is a big pain. The invention of high-end video door phones is substantially getting more popular in the market. It provides live conversation with the person without even opening of main door.

Adoption of smart technology and smart control of devices with the help of smart phones is also one of the major reasons behind growing need for automated home security system. Door phones connected with smart phones have special feature, which allows user to control the access of visitors even if when they are not in home. Moreover, advancements in door phones including addition of security alarms, quick access through biometric sensors, and smart control provide a growth opportunity for the market.

Asia Pacific is expected to expand at the highest CAGR of 7.6% over the forecast period. The market is driven by increasing number of construction activities in the residential sector. Moreover, growing concerns over safety and security of people who are living alone in their houses are driving this market. Commercial spaces are also installing these devices at various locations for giving advanced level of safety and security to the employees. Audio door phones accounted for the largest market share in 2018 owing to their increased usage in commercial spaces.

Various strategic initiatives such as new product launches, expansion, and mergers and acquisitions are taken by the key players in order to increase the brand presence in the market. Some of the key players in the business are Aiphone Corporation; Panasonic Corporation; Fermax Holding Investment SL; 1byone, Inc.; Honeywell International Inc.; ABB Genway; and Legrand. For instance, in August 2018, Panasonic Corporation launched a wireless video door phone, along with a voice change function.

Door Phone Market Report Highlights
  • By product, the video door phone segment is expected to grow at the fastest CAGR over the forecast period. The increasing demand for advanced security solutions in residential and commercial spaces is a significant driver.
  • The residential segment dominated the market with the largest revenue share of 67.6% in 2024, owing to the increasing adoption of smart home technologies and heightened home security awareness among homeowners.
  • North America door phone market dominated the global market with the largest revenue share of 32.1% in 2024 and is expected to grow over the forecast period owing to the region's advanced technology infrastructure and high adoption rate of smart home devices.
  • Various manufacturers are concentrating on new product launches, marketing campaigns, and technological innovation to estimate existing and future demand patterns from upcoming product segments.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. End Use
1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. End use outlook
2.3. Competitive Insights
Chapter 3. Pacemaker Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Rising prevalence of cardiovascular diseases (CVD)
3.2.1.2. Favorable reimbursement policies
3.2.1.3. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. Stringent regulation and approvals
3.2.2.2. Product Recalls
3.3. Pacemaker Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Pacemaker Market: Product Estimates & Trend Analysis
4.1. Global Pacemaker Market: Product Dashboard
4.2. Global Pacemaker Market: Product Movement Analysis
4.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
4.4. External Pacemakers
4.4.1. External pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.2. Single Chamber
4.4.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.4.3. Dual Chamber
4.4.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.5. Implantable Pacemakers
4.5.1. Implantable pacemakers market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2. Conventional
4.5.2.1. Conventional market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2.2. Single Chamber
4.5.2.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2.3. Dual Chamber
4.5.2.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.2.4. Biventricular Chamber
4.5.2.4.1. Biventricular Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.3. Leadless
4.5.3.1. Leadless market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.3.2. Single Chamber
4.5.3.2.1. Single Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
4.5.3.3. Dual Chamber
4.5.3.3.1. Dual Chamber market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 5. Pacemaker Market: Application Estimates & Trend Analysis
5.1. Global Pacemaker Market: Application Dashboard
5.2. Global Pacemaker Market: Application Movement Analysis
5.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
5.4. Bradycardia
5.4.1. Bradycardia market estimates and forecasts 2018 to 2030 (USD Billion)
5.5. Acute Myocardial Infarction
5.5.1. Acute myocardial infarction market estimates and forecasts 2018 to 2030 (USD Billion)
5.6. Arrhythmias
5.6.1. Arrhythmias market estimates and forecasts 2018 to 2030 (USD Billion)
5.6.2. Atrial Fibrillation
5.6.2.1. Atrial Fibrillation market estimates and forecasts 2018 to 2030 (USD Billion)
5.6.3. Heart Block
5.6.3.1. Heart Block market estimates and forecasts 2018 to 2030 (USD Billion)
5.6.4. Long QT Syndrome
5.6.4.1. Long QT syndrome market estimates and forecasts 2018 to 2030 (USD Billion)
5.7. Congestive Heart Failure
5.7.1. Congestive heart failure market estimates and forecasts 2018 to 2030 (USD Billion)
5.8. Others
5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 6. Pacemaker Market: End Use Estimates & Trend Analysis
6.1. Global Pacemaker Market: End Use Dashboard
6.2. Global Pacemaker Market: End Use Movement Analysis
6.3. Global Pacemaker Market Size & Forecasts and Trend Analysis, 2018 to 2030
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Billion)
6.5. Outpatient Facilities
6.5.1. Outpatient Facilities market estimates and forecasts 2018 to 2030 (USD Billion)
Chapter 7. Cardiovascular Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, and End-use
7.1. Regional Dashboard
7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
7.3.1. U.S.
7.3.1.1. Key country dynamics
7.3.1.2. Regulatory framework/ reimbursement structure
7.3.1.3. Competitive scenario
7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Canada
7.3.2.1. Key country dynamics
7.3.2.2. Regulatory framework/ reimbursement structure
7.3.2.3. Competitive scenario
7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.3.3. Mexico
7.3.3.1. Key country dynamics
7.3.3.2. Regulatory framework/ reimbursement structure
7.3.3.3. Competitive scenario
7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Key country dynamics
7.4.1.2. Regulatory framework/ reimbursement structure
7.4.1.3. Competitive scenario
7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.4.2. Germany
7.4.2.1. Key country dynamics
7.4.2.2. Regulatory framework/ reimbursement structure
7.4.2.3. Competitive scenario
7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.4.3. France
7.4.3.1. Key country dynamics
7.4.3.2. Regulatory framework/ reimbursement structure
7.4.3.3. Competitive scenario
7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.4.4. Italy
7.4.4.1. Key country dynamics
7.4.4.2. Regulatory framework/ reimbursement structure
7.4.4.3. Competitive scenario
7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.4.5. Spain
7.4.5.1. Key country dynamics
7.4.5.2. Regulatory framework/ reimbursement structure
7.4.5.3. Competitive scenario
7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.4.6. Norway
7.4.6.1. Key country dynamics
7.4.6.2. Regulatory framework/ reimbursement structure
7.4.6.3. Competitive scenario
7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.4.7. Sweden
7.4.7.1. Key country dynamics
7.4.7.2. Regulatory framework/ reimbursement structure
7.4.7.3. Competitive scenario
7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.4.8. Denmark
7.4.8.1. Key country dynamics
7.4.8.2. Regulatory framework/ reimbursement structure
7.4.8.3. Competitive scenario
7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Key country dynamics
7.5.1.2. Regulatory framework/ reimbursement structure
7.5.1.3. Competitive scenario
7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. China
7.5.2.1. Key country dynamics
7.5.2.2. Regulatory framework/ reimbursement structure
7.5.2.3. Competitive scenario
7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. India
7.5.3.1. Key country dynamics
7.5.3.2. Regulatory framework/ reimbursement structure
7.5.3.3. Competitive scenario
7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.5.4. Australia
7.5.4.1. Key country dynamics
7.5.4.2. Regulatory framework/ reimbursement structure
7.5.4.3. Competitive scenario
7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.5.5. South Korea
7.5.5.1. Key country dynamics
7.5.5.2. Regulatory framework/ reimbursement structure
7.5.5.3. Competitive scenario
7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.5.6. Thailand
7.5.6.1. Key country dynamics
7.5.6.2. Regulatory framework/ reimbursement structure
7.5.6.3. Competitive scenario
7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Key country dynamics
7.6.1.2. Regulatory framework/ reimbursement structure
7.6.1.3. Competitive scenario
7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.6.2. Argentina
7.6.2.1. Key country dynamics
7.6.2.2. Regulatory framework/ reimbursement structure
7.6.2.3. Competitive scenario
7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Key country dynamics
7.7.1.2. Regulatory framework/ reimbursement structure
7.7.1.3. Competitive scenario
7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Key country dynamics
7.7.2.2. Regulatory framework/ reimbursement structure
7.7.2.3. Competitive scenario
7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. UAE
7.7.3.1. Key country dynamics
7.7.3.2. Regulatory framework/ reimbursement structure
7.7.3.3. Competitive scenario
7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. Kuwait
7.7.4.1. Key country dynamics
7.7.4.2. Regulatory framework/ reimbursement structure
7.7.4.3. Competitive scenario
7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Profiles
8.4.1. Osypka Medical GmbH
8.4.1.1. Company overview
8.4.1.2. Financial performance
8.4.1.3. Product benchmarking
8.4.1.4. Strategic initiatives
8.4.2. Zoll Medical Corporation
8.4.2.1. Company overview
8.4.2.2. Financial performance
8.4.2.3. Product benchmarking
8.4.2.4. Strategic initiatives
8.4.3. Medtronic
8.4.3.1. Company overview
8.4.3.2. Financial performance
8.4.3.3. Product benchmarking
8.4.3.4. Strategic initiatives
8.4.4. BIOTRONIK
8.4.4.1. Company overview
8.4.4.2. Financial performance
8.4.4.3. Product benchmarking
8.4.4.4. Strategic initiatives
8.4.5. MicroPort Scientific Corporation
8.4.5.1. Company overview
8.4.5.2. Financial performance
8.4.5.3. Product benchmarking
8.4.5.4. Strategic initiatives
8.4.6. MEDICO SpA
8.4.6.1. Company overview
8.4.6.2. Financial performance
8.4.6.3. Product benchmarking
8.4.6.4. Strategic initiatives
8.4.7. Pacetronix
8.4.7.1. Company overview
8.4.7.2. Financial performance
8.4.7.3. Product benchmarking
8.4.7.4. Strategic initiatives
8.4.8. Oscor Inc
8.4.8.1. Company overview
8.4.8.2. Financial performance
8.4.8.3. Product benchmarking
8.4.8.4. Strategic initiatives
8.4.9. Boston Scientific Corporation
8.4.9.1. Company overview
8.4.9.2. Financial performance
8.4.9.3. Product benchmarking
8.4.9.4. Strategic initiatives
8.4.10. Lepu Medical Technology (Beijing) Co., Ltd.
8.4.10.1. Company overview
8.4.10.2. Financial performance
8.4.10.3. Product benchmarking
8.4.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings